Bruker (BKD) AI Stock Analysis

Company Guidance

Bruker reiterated FY‑2026 guidance of $3.54–$3.57 billion in revenues (reported growth 3%–4%), with organic growth of 1%–2% and M&A contributing ~1.5%; foreign exchange is now a ~0.5% revenue tailwind (vs. prior 1.5%), and the company still expects non‑GAAP operating margin expansion of 250–300 basis points year‑over‑year and non‑GAAP EPS of $2.10–$2.15 (roughly +15%–17% vs. FY‑2025) after factoring a higher effective tax rate. Management said it remains on track for $140 million of annualized cost savings in 2026 (with an additional ~$20 million of savings expected from the new operating structure in 2027), noted net leverage was 2.8x at 6/30/26, and disclosed a ~ $20 million Q3→Q4 revenue timing shift that leaves Q3 organic revenue roughly flat to slightly up (with a slight sequential margin/EPS dip) and sets up a meaningful sequential and year‑over‑year improvement in Q4 (management indicated Q4 could be around the ~$1 billion level); guidance reflects FX and tax assumptions as of June 30, 2026 and incorporates the earlier‑than‑expected U.S. tariff refunds that added ~200 bps to Q2 operating margin and about $0.06 to Q2 EPS.